Purchase order 4800180392

The University of Nebraska Medical Center, a state agency under the Board of Regents of the University of Nebraska, awarded a purchase order to Cell Signaling Technology Inc., a vendor based in Boston, Massachusetts, for the procurement of laboratory reagents. The contract, issued on February 18, 2026, under Purchase Order number 4800180392, calls for the delivery of one unit of HSP70 Antibody (material number 4872S) to the University of Nebraska Medical Center facility located at 601 South Saddle Creek Road, Omaha, Nebraska. The total contract value is $317.00, with a delivery date of March 4, 2026.

The purchase order specifies standard commercial terms including Net 30 payment terms, with freight prepaid and Free on Board (F.O.B.) destination. Cell Signaling Technology Inc. is required to acknowledge acceptance of the order within ten days of issuance and to include the purchase order number on all packages, invoices, and related documentation. The University of Nebraska's tax-exempt status (number 05-8905401) applies to this transaction. The period of performance extends from the award date of February 18, 2026, through the scheduled completion date of March 4, 2026.